Characteristics and outcomes for patients with heart failure diagnosed according to the universal definition and classification of heart failure. Data from a single-center registry.

epidemiology heart failure heart failure with mildly reduced ejection fraction heart failure with preserved ejection fraction heart failure with reduced ejection fraction

Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
2024
Historique:
received: 26 02 2024
accepted: 26 02 2024
medline: 8 5 2024
pubmed: 17 3 2024
entrez: 17 3 2024
Statut: ppublish

Résumé

There are no data on the characteristics and outcomes for patients with heart failure (HF) with reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) ejection fraction diagnosed according to the universal definition and classification of HF. We used the universal HF definition to compare baseline characteristics, hospital readmission and mortality rates in individuals with HFrEF, HFmrEF, and HFpEF diagnosed retrospectively. The study was designed as a single-center retrospective analysis of all consecutive 40732 hospital admissions between 2013 and 2021 in a tertiary department of cardiology. All patients with HF, defined according to the universal definition and classification of HF, were identified. The study included 8471 patients with a mean age of 65.1 (12.8) years, of whom 2823 (33.3%) were females. Most individuals had a prior diagnosis of HF (76.3%) and elevated N-terminal pro-B-type natriuretic peptide levels (99.0%) with a median of 1548 (629-3786) pg/ml. Mean ejection fraction (EF) was 36.2 (14.9)%. The median follow-up was 39.1 (18.1-70.5) months. The most frequent type of HF was HFrEF (n = 4947; 58.4%), followed by HFpEF (n = 1138; 28.2%) and HFmrEF (n = 2386; 13.4%). Urgent HF readmissions and all-cause deaths were highest in HFrEF (40.8% and 42.7%), followed by HFmrEF (25.4% and 31.5%) and HFpEF (15.2% and 23.8%, respectively). The highest rates of urgent HF readmissions and all-cause mortality were observed in patients with HFrEF, followed by HFmrEF and HFpEF. In all HF groups, the all-cause mortality rate was higher than the rates of urgent HF readmission.

Sections du résumé

BACKGROUND BACKGROUND
There are no data on the characteristics and outcomes for patients with heart failure (HF) with reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) ejection fraction diagnosed according to the universal definition and classification of HF.
AIMS OBJECTIVE
We used the universal HF definition to compare baseline characteristics, hospital readmission and mortality rates in individuals with HFrEF, HFmrEF, and HFpEF diagnosed retrospectively.
RESULTS RESULTS
The study was designed as a single-center retrospective analysis of all consecutive 40732 hospital admissions between 2013 and 2021 in a tertiary department of cardiology. All patients with HF, defined according to the universal definition and classification of HF, were identified. The study included 8471 patients with a mean age of 65.1 (12.8) years, of whom 2823 (33.3%) were females. Most individuals had a prior diagnosis of HF (76.3%) and elevated N-terminal pro-B-type natriuretic peptide levels (99.0%) with a median of 1548 (629-3786) pg/ml. Mean ejection fraction (EF) was 36.2 (14.9)%. The median follow-up was 39.1 (18.1-70.5) months. The most frequent type of HF was HFrEF (n = 4947; 58.4%), followed by HFpEF (n = 1138; 28.2%) and HFmrEF (n = 2386; 13.4%). Urgent HF readmissions and all-cause deaths were highest in HFrEF (40.8% and 42.7%), followed by HFmrEF (25.4% and 31.5%) and HFpEF (15.2% and 23.8%, respectively).
CONCLUSIONS CONCLUSIONS
The highest rates of urgent HF readmissions and all-cause mortality were observed in patients with HFrEF, followed by HFmrEF and HFpEF. In all HF groups, the all-cause mortality rate was higher than the rates of urgent HF readmission.

Identifiants

pubmed: 38493451
pii: VM/OJS/J/99549
doi: 10.33963/v.phj.99549
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-397

Auteurs

Jacek T Niedziela (JT)

3rd Department of Cardiology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Zabrze, Poland. jniedziela@sum.edu.pl.
3rd Department of Cardiology, Silesian Centre for Heart Disease, Zabrze, Poland. jniedziela@sum.edu.pl.

Piotr Rozentryt (P)

3rd Department of Cardiology, Silesian Centre for Heart Disease, Zabrze, Poland.
Department of Social Medicine and Prevention, School of Public Health in Bytom, Medical University of Silesia in Katowice, Bytom, Poland.

Jolanta Nowak (J)

3rd Department of Cardiology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Zabrze, Poland.
3rd Department of Cardiology, Silesian Centre for Heart Disease, Zabrze, Poland.

Bożena Szyguła-Jurkiewicz (B)

3rd Department of Cardiology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Zabrze, Poland.
3rd Department of Cardiology, Silesian Centre for Heart Disease, Zabrze, Poland.

Łukasz Pyka (Ł)

3rd Department of Cardiology, Silesian Centre for Heart Disease, Zabrze, Poland.

Daniel Cieśla (D)

Department for Science, Education and New Medical Technologies, Silesian Centre for Heart Disease, Zabrze, Poland.

Mariusz Gąsior (M)

3rd Department of Cardiology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Zabrze, Poland.
3rd Department of Cardiology, Silesian Centre for Heart Disease, Zabrze, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH